Medical devices, healthcare technology and the business of care
510(k) clearance · K262447

The Circadia CX00 System (CX00)

Circadia Health, Inc. · Decision date Oct 15, 2026

MEDTECHLEDGER EXPLANATIONK262447

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-15 for K262447, The Circadia CX00 System (CX00), submitted by Circadia Health, Inc. of El Segundo, California. The filing was received 07/16/2026 as a traditional 510(k), reviewed by the Cardiovascular panel, and not reviewed by a third party. The classification product code is DRT (cardiac monitor, including cardiotachometer and rate alarm) under regulation 870.2300, with BZQ listed as a subsequent product code. SESE means clearance to market, not PMA approval.

The public record does not describe the device's components, the specific change or comparison to a predicate device, or any performance data, and no summary statement appears in the public information. The TPLC listing shows earlier Circadia submissions K252676 and K261286 for the Circadia C300 System, but the record does not establish a predicate relationship between those clearances and CX00. No predetermined change control plan was authorized, and the device was not recorded as a combination product.

Clinical performance, indications for use, and labeling remain outside the supplied record and should be read from the original FDA documents rather than inferred from this clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 15, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262447
Regulatory pathway
510(k) premarket notification
Product code
DRT
Decision code
SESE
Decision date
Oct 15, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Monitor, Cardiac (Incl. Cardiotachometer & Rate Alarm).

Product code
DRT
FDA device class
2

FDA decision timeline

  1. K262447 received

    Application receipt date recorded by FDA.

  2. K262447 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DRT

Product / regulatory recordCompanyPathwayDecision dateSource
Life Detection Technologies510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Circadia Health, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
El Segundo, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records